Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated…

How China-Fiji fisheries cooperation reels in economic vitality for the island nation

GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ — News report from South. jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”…

Omio's annual NowNext '25 report reveals a new era of intentional travel

From ‘World of Mouth’ and ‘Beach Please’ to ‘Travel Thrifties’ and ‘Generation…

CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025

HONG KONG, Oct. 17, 2025 /PRNewswire/ — CLPS Incorporation (the "Company" or "CLPS")…

Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI

HANGZHOU, China, Oct. 17, 2025 /PRNewswire/ — Kevin Kelly, founding executive editor…

Future-Ready Together: CEAT Specialty Partners with Mahindra & Mahindra for OJA Tractor Launch in Australia

CEAT Specialty chosen as the preferred OEM tyre partner for Mahindra’s future-ready…

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ — The New York Stock Exchange…

SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation

HONG KONG, Oct. 17, 2025 /PRNewswire/ — GIBO Holdings Ltd. (NASDAQ: GIBO), Asia’s…